中东和非洲血浆衍生物市场预测至 2028 年 - COVID-19 影响和按类型（白蛋白、因子 VIII、因子 IX、免疫球蛋白、超免疫球蛋白等）、应用（血友病、低丙种球蛋白血症、免疫缺陷病、血管性血友病）的区域分析疾病等）和最终用户（医院、诊所等）
No. of Pages: 145 | Report Code: BMIRE00028476 | Category: Life Sciences
No. of Pages: 145 | Report Code: BMIRE00028476 | Category: Life Sciences
免疫球蛋白G (IgG) 疗法广泛用于治疗由遗传引起的原发性免疫缺陷。由于人们对 IgG 疗法的认识不断提高，过去几年对 IgG 的需求一直在稳步增长。这一增长也归因于其新确定的适应症的新疗法。根据网络荟萃分析 (NMA) 进行的对照试验，IgG 疗法已被批准用于治疗格林-巴利综合征；综合征（GBS）、慢性炎症性脱髓鞘性多发性神经病（CIDP）、多灶性运动神经病（MMN）和皮肌炎。免疫球蛋白 G (IgG) 疗法对于治疗重症肌无力加重和僵人综合症也有效。此外，它对癫痫、神经脊髓炎和自身免疫性脑炎等自身免疫性疾病也具有令人信服的功效。
很大一部分 IgG 用于免疫学以外的专业，例如肿瘤学、神经病学、血液学和风湿病学。与所有专业相比，神经病学是全球市场上增长最快的专业。免疫球蛋白G市场的增长归因于其被批准用于治疗慢性炎症性脱髓鞘性多发性神经病（CIDP），随后又被批准用于治疗淋巴瘤、骨髓瘤和白血病引起的继发性免疫缺陷以及某些免疫抑制疗法尤其是B细胞靶向治疗。因此，在标签内和标签外处方的多种治疗中，IgG 的广泛使用将在未来几年继续扩大并推动全球市场的 IgG 需求。
中东和非洲非洲血浆衍生品市场已细分为阿联酋、沙特阿拉伯、南非以及中东其他地区和地区。非洲。沙特阿拉伯预计将占据最大的市场份额，并有望在中东和中东地区适度提升。非洲。该地区血友病、血管性血友病和其他出血性疾病的患病率很高，因此越来越多地采用血浆衍生物产品进行治疗。此外，市场参与者和政府之间的各种合作伙伴关系也正在推动血浆衍生物用于治疗的采用，从而促进市场增长。例如，2021 年 10 月，Grifols 和埃及国家服务项目组织 (NSPO) 在开罗启用了第一个非洲血浆供应平台，作为实现血浆衍生药物自给自足联盟的一部分。这将增加中东、非洲和其他国家对血浆产品的获取，从而促进市场增长。
中东和非洲非洲血浆衍生物市场按类型、应用、最终用户和国家细分。
中东和非洲非洲血浆衍生物市场按类型分为白蛋白、因子VIII、因子IX、免疫球蛋白、超免疫球蛋白等。免疫球蛋白细分市场到 2022 年将占据更大的市场份额。
根据应用情况，中东和非洲地区将占据更大的市场份额。非洲血浆衍生物市场分为血友病、低丙种球蛋白血症、免疫缺陷病、冯维勒布兰德病等应用。到 2022 年，免疫缺陷疾病应用领域将占据最大的市场份额。
血浆衍生物市场按最终用户划分，分为医院、诊断实验室、诊所和其他最终用户。到 2022 年，医院细分市场占据最大市场份额。
按国家/地区、中东和非洲地区划分。非洲血浆衍生品市场分为沙特阿拉伯、南非、阿联酋以及中东其他地区和地区。非洲。沙特阿拉伯将在 2022 年占据市场主导地位。
Grifols SA； SK等离子有限公司；奥克塔制药公司；莫诺宾德公司；英塔斯制药有限公司； CSL 贝林有限责任公司； LFB SA; Kedrion SpA；和 Fusion Health Care Pvt Ltd 是在中东和中东地区运营的领先公司。非洲血浆衍生品市场。
Strategic insights for Middle East & Africa Blood Plasma Derivatives involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 1,402.51 Million |
| Market Size by 2028 | US$ 2,223.69 Million |
| Global CAGR (2022 - 2028) | 8.0% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 中东和非洲
|
| Market leaders and key company profiles |
The regional scope of Middle East & Africa Blood Plasma Derivatives refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Middle East & Africa Blood Plasma Derivatives Market is valued at US$ 1,402.51 Million in 2022, it is projected to reach US$ 2,223.69 Million by 2028.
As per our report Middle East & Africa Blood Plasma Derivatives Market, the market size is valued at US$ 1,402.51 Million in 2022, projecting it to reach US$ 2,223.69 Million by 2028. This translates to a CAGR of approximately 8.0% during the forecast period.
The Middle East & Africa Blood Plasma Derivatives Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Blood Plasma Derivatives Market report:
The Middle East & Africa Blood Plasma Derivatives Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East & Africa Blood Plasma Derivatives Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East & Africa Blood Plasma Derivatives Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East & Africa Blood Plasma Derivatives Market
